Home
Lupin Ltd 52 Week High

Lupin Ltd
NSE: LUPIN
YEARHIGH
Key Highlights
- The 52 Week HIGH of Lupin Ltd is ₹ 2403 as of 21 Feb 25 .
Company Fundamentals for Lupin Ltd
Market Price of Lupin Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 1906.15 |
20 Feb 2025 | 1977.6 |
19 Feb 2025 | 1977 |
18 Feb 2025 | 2012.95 |
17 Feb 2025 | 2025.65 |
14 Feb 2025 | 1968.55 |
13 Feb 2025 | 2055.65 |
12 Feb 2025 | 2024.9 |
11 Feb 2025 | 2066.4 |
10 Feb 2025 | 2169.85 |
Asset Value vs Market Value of Lupin Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Historical Revenue of Lupin Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Lupin Ltd
Historical Net Profit of Lupin Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Lupin Ltd
Lupin Ltd News Hub
Lupin launches Mirabegron Extended-Release Tablets in US
Lupin announced the launch of Mirabegron Extended-Release Tablets, 50 mg, in the United States, aft
Read more
04 Sept 24
Lupin Ltd soars 2.88%
Lupin Ltd is up for a third straight session in a row. The stock is quoting at Rs 2109.95, up 2.88%
Read more
09 Aug 24
Broader mkt rallies; metal shares advance
The benchmark indices continued to trade with strong gains in mid-morning trade. The Nifty traded ab
Read more
07 Aug 24
Lupin hits 52-week high after Q1 PAT climbs 76% YoY to Rs 801 cr in FY25
Revenue from operations increased 16.28% YoY to Rs 5,514.34 crore during the quarter. Profit before
Read more
07 Aug 24